Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Antiviral Agents

Retention of Metabolites of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells

Xin Wang, Hiromichi Tanaka, Masanori Baba, Yung-chi Cheng
Xin Wang
1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiromichi Tanaka
2School of Pharmaceutical Sciences, Showa University, Tokyo 142-8555, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Baba
3Division of Antiviral Chemotherapy, Center for Chronic Viral Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yung-chi Cheng
1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yccheng@yale.edu
DOI: 10.1128/AAC.00302-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    (A to C) Time- and concentration-dependent intracellular accumulation of 4′-Ed4T radioactive metabolites in CEM cells. CEM cells were incubated in the presence of various concentrations of [3H]4′-Ed4T. At different time intervals, the cells were harvested and extracted with 70% cold methanol. The extracts were subjected to HPLC analyses. The radioactivity detected was calculated as the number of picomoles/106 cells for 4′-Ed4TMP (A), 4′-Ed4TDP (B), and 4′-Ed4TTP (C). The data points represent the means ± standard deviations of triplicate determinations. (D to F) Intracellular persistence of 4′-Ed4T radioactive metabolites in CEM cells. CEM cells were incubated with various concentrations of [3H]4′-Ed4T for 15 h and thoroughly washed to remove the extracellular drug. After further incubation of the cells for 0, 2, 4, 8, 12, and 24 h, cell extracts were prepared and subjected to HPLC analyses. The radioactivity detected was calculated as the numbers of picomoles/106 cells for 4′-Ed4TMP (D), 4′-Ed4TDP (E), and 4′-Ed4TTP (F). The data points represent the means ± standard deviations of triplicate determinations.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Time- and temperature-dependent efflux of 4′-Ed4T (A), AZT (B), and/or their metabolites from CEM cells. CEM cells were preincubated with 1 μM of [3H]4′-Ed4T and [3H]AZT for 15 h. The cells were then washed with PBS and resuspended in fresh medium without drugs. At different time intervals, the cells and media were harvested and extracted with 70% cold methanol. The metabolites in the extracts were determined by the DE-81 disc assay. The amounts of extracellular 4′-Ed4T (A), AZT (B), and/or their metabolites in the medium are shown. (C) Ratio of efflux of 4′-Ed4T, AZT, and/or their metabolites as a percentage of the total metabolites.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Efflux of 4′-Ed4T, AZT, and/or their metabolites from CEM cells. CEM cells were preincubated with 1 μM (A) or 0.1 μM (B) of [3H]AZT or 1 μM of [3H]4′-Ed4T (C) for 15 h. The cells were then washed with PBS and resuspended in fresh medium for another 2 h. The harvested media were concentrated and then extracted with 70% cold methanol. The extracts were subjected to HPLC. The insets in each panel are enlargements of the areas for the monophosphate peaks.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Effect of the nucleoside inhibitor dipyridamole on the efflux and influx of 4′-Ed4T and AZT in CEM cells. For the efflux study, CEM cells were cultured with 2 μM of [3H]AZT or [3H]4′-Ed4T. After 15 h, the cells were washed and resuspended in fresh medium with different concentrations of dipyridamole. The cells and media were harvested after 2 h of incubation and extracted with 70% cold methanol. The metabolites in the extracts were determined by the DE-81 disc assay. (A) Effect of dipyridamole on the efflux of 4′-Ed4T and AZT; (B) effect of dipyridamole on the efflux of AZT nucleoside and its monophosphate metabolite; (C) effect of dipyridamole on the influx of thymidine, 4′-Ed4T, and AZT in CEM cells. For the influx study, CEM cells were incubated with various concentrations of dipyridamole at 37°C for 15 min prior to the uptake assays. [3H]thymidine, [3H]AZT, or [3H]4′-Ed4T was added to the cells for times ranging from 1 to 30 min. Uptake was terminated by the addition of ice-cold PBS containing 20 μM dipyridamole. The cells were washed with the same buffer and solubilized with 1% Sarkosyl. The radioactivity was determined in a liquid scintillation counter.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effect of downregulation of MRP4 on the efflux of 4′-Ed4TMP and AZTMP. (A) Expression of MRP4 in Tet-On RKO/shMRP4 cells, as detected by Western blotting. Actin was used as the internal control. (B) Doxycycline (Dox)-induced Tet-On RKO/shMRP4 cells were pretreated with 5 μM of [3H]4′-Ed4T or 2 μM of [3H]AZT for 16 h. The cells were then washed with ice-cold PBS and resuspended in fresh medium. The cell and medium extracts were prepared and subjected to the DE-81 disc assay. The radioactivity detected was calculated as the numbers of picomoles of total intracellular or extracellular monophosphate metabolites for 4′-Ed4T and AZT.

PreviousNext
Back to top
Download PDF
Citation Tools
Retention of Metabolites of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells
Xin Wang, Hiromichi Tanaka, Masanori Baba, Yung-chi Cheng
Antimicrobial Agents and Chemotherapy Jul 2009, 53 (8) 3317-3324; DOI: 10.1128/AAC.00302-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Retention of Metabolites of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Retention of Metabolites of 2′,3′-Didehydro-3′-Deoxy-4′-Ethynylthymidine, a Novel Anti-Human Immunodeficiency Virus Type 1 Thymidine Analog, in Cells
Xin Wang, Hiromichi Tanaka, Masanori Baba, Yung-chi Cheng
Antimicrobial Agents and Chemotherapy Jul 2009, 53 (8) 3317-3324; DOI: 10.1128/AAC.00302-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-HIV Agents
stavudine
Thymidine

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596